FRACTIONATION |
Author [ref] |
Year |
Treatment Interval |
Follow up years (range) |
n pat |
Dose/Session (Gy) |
Total Dose (GY) |
~BED2Gy a/b=2Gy/3Gy |
% BPN [grade] |
Interval to BPN mean (range) |
|
[33] |
1996 |
1958-1962 |
na (na - 2.5) |
33 |
4.58 |
55 |
90/83 |
73% [1-3] |
0.5-2.5 y |
|
|
|
|
|
84 |
4.25 |
51 |
80/74 |
15% [1-3] |
0.5-2 y |
|
[14] |
1987 |
1980-1983 |
na (na - 7) |
250 |
3.4 |
51 |
69/66 |
2.4% [1 and 3] |
0.3-2 y |
H |
[31] |
1990 |
1982-1984 |
na (3-5.5) |
338 |
3 |
45 |
56/54 |
5.90% |
(1-4 year) |
|
[9] |
1995 |
1981-NA |
median 8 (2-11) |
113 |
2.67 |
40 |
47/46 |
0% |
0 |
|
[26] |
1995 |
1981-NA |
median 8 (1-11) |
334 |
2.67 |
40 |
47/46 |
0% |
0 |
Y |
[32] |
1997 |
1979-1986 |
median 12.5 (na) |
164 |
2.19 |
35 |
37/36 |
0% |
0 |
|
[29] |
2000 |
1963-1965 |
(na - 34) |
71 |
4 |
44 |
66/62 |
63% [1-4] |
4.2y (<1-19 y |
|
[24] |
2000 |
1989-1992 |
alive: median 5.9 (na - 10) |
1148 |
2.66 |
40 |
47/46 |
0% |
0 |
P |
[27]* |
2002 |
1984-1999 |
(na - 10) |
89 |
6 |
30 |
60/55 |
0% [2-4] |
0 |
|
[25] |
2004 |
1980-1993 |
median 7.3 (2.5-18) |
332 |
2.6 |
52 |
60/58 |
14% [1-4] |
>/=G3: 0.8%/ y |
|
[1] |
2008 |
1999-2002 |
median 5.1 (max. 8.0) |
119 |
3.2 |
42 |
54/52 |
0.1%[1] |
2y |
O |
[2] |
2008 |
1999-2001 |
median 6 (max. 8.0) |
74 |
2.67 |
40 |
47/46 |
0 |
0 |
|
[3] |
2013 |
1999-2002 |
median 9.3 (max. 12.4) |
193 |
3.20 or 2.67 |
41.6/40 |
54/52;47/46 |
none mentioned |
0 |
|
own study |
2014 |
1967-1977 |
median 26.6 (7-45.2) |
124 |
3.3 |
43 |
56/54 |
1% [2] |
25y |
|
[30] |
1992 |
19968-1985 |
median 6.6 (<1-19) |
1117 |
2 |
50 |
50 |
1.8% [1-2] |
10 months (1.5-77) |
N |
[13] |
1993 |
1982-1990 |
median 4 |
128 |
2 |
|
50 |
9%/5% [1/3 |
no latency |
O |
[31] |
1990 |
1982-1984 |
(3-5.5) |
111 |
1.8 |
54 |
51 |
1% [?] |
(1-4 years) |
R |
[28] |
1990 |
1977-1985 |
median 10 |
697 |
2 |
50 |
50 |
<1% [na] |
na |
M |
[1] |
2008 |
1999-2002 |
median 5.1 (max. 8.0) |
309 |
2 |
50 |
50 |
0% |
0 |
O |
[2] |
2008 |
1999-2001 |
median 6 (max. 8.0) |
153 |
2 |
50 |
50 |
0% |
0 |
|
[3] |
2013 |
1999-2002 |
median 9.3 (max. 12.4) |
462 |
2 |
50 |
50 |
none mentioned |
0 |
*postoperative axillary radiation after axillary melanoma
metastasis dissection, 2 fractions/week. |